Clinical Trial Update: Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Taxotere (docetaxel) in combination with oxaliplatin for squamous cell carcinoma of the head and neck; the trial was terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Southern California | Conditions: Carcinoma of the Head and Neck | Phase 2 | Status: TERMINATED | Results posted: 2013-05-06